Alexander I. Spira, MD, PhD, FACP, discusses the clinical implications of ctDNA for treatment decisions and monitoring in ...

The combination of Opdivo and Yervoy is supported by updated results as a standard of care for MSI-H or dMMR metastatic ...

Siena basketball's Alden Yergey said she's looking at Thursday's "Pink Zone" game against Marist at UHY Center in a different ...

The documentary follows Isabella Strahan's difficult journey after being diagnosed with medulloblastoma, an aggressive form of brain cancer ...

Washington, D.C. (7News) — January marks National Thyroid Awareness Month. On Wednesday, Thyroid Cancer survivor, Brittany ...

"Good Morning America" host Michael Strahan said it’s “hard to relive” Isabella’s cancer journey, which is documented in the ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

With a focus on healthy living and information on advances in breast cancer treatment, Mayo Clinic is holding an educational event at Donna Marathon.

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

New cell therapy, Cilta-cel, shows promise in the treatment of multiple myeloma, providing a personalised approach with the ...

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

Triple negative breast cancer wreaks a particularly heavy toll in certain regions and populations, with stark differences in both incidence and survival rates ...